Abbott
Top 10 Articles on 360Dx in 2021
Not surprisingly, the year in diagnostics was dominated by COVID-19 testing, particularly the growing at-home antigen test market.
Becton Dickinson, Siemens Healthineers, Abbott Laboratories, Others Nab FDA Clearances in November
BioMérieux obtained FDA clearance for a multiplex RT-PCR assay that detects SARS-CoV-2 RNA in nasopharyngeal swabs from symptomatic individuals.
While molecular testing will provide the definitive answer, analysis of the variant's mutations suggest most rapid antigen tests will still pick up the virus.
Broader Markets Lift 360Dx Index 3 Percent in October
Of the 29 companies in the index, 14 saw increases in their stock prices, while 15 saw declines.
The firm more than doubled its COVID-19 testing-related revenues during Q3 compared to a year ago. Around 84 percent of the revenues were for rapid screening tests.
Sep 22, 2021
Jun 2, 2021